The Impact of Churn on HIV Outcomes in a Southern United States Clinical Cohort Restricted; Files Only

Gopalsamy, Srinivasa Nithin (Spring 2022)

Permanent URL: https://etd.library.emory.edu/concern/etds/5712m788q?locale=pt-BR
Published

Abstract

Background. Persons with HIV (PWH) may experience a cycle of engaging and disengaging in care in a phenomenon designated as “churn.” While HIV churn is predicted to be more prevalent in the southern United States, it has not been well characterized in this region.

Methods. We conducted a retrospective cohort study involving PWH newly establishing care at a large, urban clinic in Atlanta, Georgia from 2012 to 2017 with follow-up data collected through 2019. The primary exposure was churn, defined as a ≥12-month gap between routine clinic visits or viral load measurements. We evaluated HIV metrics, clinical outcomes, and care continuum outcomes.

Results. Of 1303 PWH newly establishing care, 81.7% were male, 84.9% Black, and 200 (15.3%) experienced churn in 3.3 years of median follow-up time. The transmissible viremia (TV) rate increased from 28.6% pre-churn to 66.2% post-churn (p-value <.0001). The 122 PWH having TV on re-engagement had delayed time to subsequent VS (aHR 0.59, 95% CI 0.48 – 0.73), and PWH returning to care contributed disproportionately to the community viral load (CVL) (% of CVL / % of patients 1.96). Churn was not associated with increased AIDS-defining illness (aOR 0.61, 95% CI 0.35 – 1.07), mortality (aHR 1.00, 95% CI 0.66 – 1.50), subsequent churn (aOR 1.53, 95% CI 0.79 – 2.97) or loss to follow-up (aOR 1.04, 95% CI 0.60 – 1.79).

Conclusions. The rate of churn in a Southern clinic was high, and those who experienced churn had increased TV at re-entry and disproportionately contributed to the CVL without early clinical or care continuum consequence.

Table of Contents

Introduction........................................................1

Methods..............................................................6

Study Design and Participants.............................. 6

Cohort Assignment.............................................. 7

Exposure and Covariates.......................................8

Outcome Variables............................................... 8

Power Analysis................................................... 12

Statistical Analyses.............................................13

Results...............................................................14

General Characteristics.......................................14

HIV Metric Outcomes......................................... 15

Clinical and Care Continuum Outcomes...............17

Discussion......................................................... 19

General Characteristics.......................................19

HIV Metric Outcomes......................................... 20

Clinical and Care Continuum Outcomes............... 21

Limitations and Future Directions....................... 25

Conclusion.........................................................26

Figures and Tables..............................................27

References..........................................................37

About this Master's Thesis

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Degree
Submission
Language
  • English
Research Field
Palavra-chave
Committee Chair / Thesis Advisor
Committee Members
Última modificação Preview image embargoed

Primary PDF

Supplemental Files